Mesothelin expression remodeled the immune-matrix tumor microenvironment predicting the risk of death in patients with malignant pleural mesothelioma

BackgroundThe combination of immunobiological agents with immune checkpoint proteins is a promising treatment for malignant pleural mesothelioma (MPM). Mesothelin and anti-PD-L1 antibody-drug conjugates specifically target malignant neoplastic cells, inhibit the migration and invasion of neoplastic...

Descripció completa

Dades bibliogràfiques

Autors principals:	Aline Nery Qualiotto, Camila Machado Baldavira, Marcelo Balancin, Alexandre Ab’Saber, Teresa Takagaki, Vera Luiza Capelozzi
Format:	Artigo
Idioma:	Inglês
Publicat:	Frontiers Media S.A. 2023-10-01
Col·lecció:	Frontiers in Immunology
Matèries:	malignant mesothelioma mesothelin PD-L1 immune cells computational quantification immunohistochemistry
Accés en línia:	https://www.frontiersin.org/articles/10.3389/fimmu.2023.1268927/full
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!